
In persons living with HIV and diabetes, the management of diabetes is lagging behind the evidence. Despite SGLT-2 inhibitors demonstrating robust clinical data in the general population, they are grossly underused in persons with HIV and diabetes.
Patel is a professor of clinical pharmacy at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California San Diego (UCSD). He maintains practices at the Antiviral Research Center as an investigational drug pharmacist and clinical pharmacist at UCSD Student Health Services.
In persons living with HIV and diabetes, the management of diabetes is lagging behind the evidence. Despite SGLT-2 inhibitors demonstrating robust clinical data in the general population, they are grossly underused in persons with HIV and diabetes.
Novel modes of delivery are imperative to improve HIV suppression and prevent transmission.
Published: December 6th 2019 | Updated: